Drugs / INV21
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01376479 | Aug → Nov 2011 | hand, foot and mouth disease | Inviragen Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | INV21 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01376479 ↗ |
| Modality | Vaccine | “an inactivated vaccine (INV21) based on the EV71 antigen will be evaluated in terms of safety and immune response” NCT01376479 ↗ |